| For: | Yang J, Wang Y, Tong XM. Sintilimab-induced autoimmune diabetes: A case report and review of the literature. World J Clin Cases 2022; 10(4): 1263-1277 [PMID: 35211559 DOI: 10.12998/wjcc.v10.i4.1263] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i4/1263.htm |
| Number | Citing Articles |
| 1 |
Huijing Dong, Shengfu Li, Yanmei Peng, Xu Zhang, Jiabin Zheng, Chongxiang Xue, Yumin Zheng, Yixuan Yu, Xingyu Lu, Zixin Hu, Huijuan Cui. Durvalumab‑induced type 1 diabetes mellitus in lung adenocarcinoma: A case report and literature review. Oncology Letters 2025; 29(6) doi: 10.3892/ol.2025.15023
|
| 2 |
Anmar Al-Taie, Najat Sheta. Clinically Approved Monoclonal Antibodies–based Immunotherapy: Association With Glycemic Control and Impact Role of Clinical Pharmacist for Cancer Patient Care. Clinical Therapeutics 2024; 46(1) doi: 10.1016/j.clinthera.2023.10.016
|
| 3 |
Hao An, Junfeng Zhao, Wenjie Chen, Ying Li, Yifei Yan, Chen Zhou, Ruyue Li, Xiujing Yao, Xue Dong, Xingying Yang, Yongjuan Hu, Jiaxuan Chen, Chuankun Han, Yingrui Bai, Yali Xu, Yintao Li. Neoadjuvant Therapy for Non‐Small Cell Lung Cancer: Recent Advances and Future Directions. Cancer Medicine 2026; 15(11) doi: 10.1002/cam4.72350
|
| 4 |
Cuiping Lin, Xuan Li, Yu Qiu, Zheng Chen, Jianping Liu. PD-1 inhibitor-associated type 1 diabetes: A case report and systematic review. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.885001
|
| 5 |
|
| 6 |
Zijian Qiu, Mixue Sun, Chunyan Dai, Xiaoping Zhu. Immunotherapy-associated autoimmune hemolytic anemia induced by anti-PD-1 therapy in esophageal cancer: A case report and literature review. Medicine 2025; 104(15) doi: 10.1097/MD.0000000000042174
|